HBK Sorce Advisory’s Boston Scientific BSX Stock Holding History

HBK Sorce Advisory’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$448K	Buy	8,302 +529	+7%	+$42.3K	0.01%	396
2025 Q4	$593K	Buy	7,773 +202	+3%	+$19.8K	0.01%	342
2025 Q3	$740K	Sell	7,571 -936	-11%	-$96.9K	0.02%	280
2025 Q2	$914K	Buy	8,507 +221	+3%	+$22.4K	0.02%	238
2025 Q1	$836K	Buy	8,286 +254	+3%	+$25.6K	0.02%	237
2024 Q4	$717K	Sell	8,032 -862	-10%	-$75.9K	0.02%	270
2024 Q3	$745K	Sell	8,894 -212	-2%	-$16.7K	0.02%	262
2024 Q2	$701K	Sell	9,106 -1,313	-13%	-$96.1K	0.02%	267
2024 Q1	$714K	Buy	+10,419	New	+$670K	0.03%	266
2023 Q4	–	Sell	-11,474	Closed	-$606K	–	574
2023 Q3	$606K	Sell	11,474 -119	-1%	-$6.24K	0.03%	279
2023 Q2	$627K	Buy	11,593 +320	+3%	+$16.7K	0.03%	281
2023 Q1	$564K	Buy	11,273 +4,669	+71%	+$220K	0.03%	302
2022 Q4	$306K	Buy	+6,604	New	+$286K	0.01%	557
2019 Q2	–	Sell	-5,767	Closed	-$221K	–	416
2019 Q1	$221K	Hold	5,767	–	–	0.02%	394
2018 Q4	$204K	Buy	+5,767	New	+$209K	0.02%	354

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HBK Sorce Advisory's BSX Position: Q1 2026 in Review

HBK Sorce Advisory increased its Boston Scientific (BSX) stake by 6.8% in Q1 2026, buying an estimated $42.3K and bringing the position to 8,302 shares worth $448K. The position accounts for 0.01% of the portfolio, ranked #396.

HBK Sorce Advisory first reported a position in BSX in Q4 2018 and has held it in 15 quarters since. The position peaked at $914K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

HBK Sorce Advisory held 8,302 shares of Boston Scientific worth $448K as of Q1 2026.
HBK Sorce Advisory bought 529 Boston Scientific shares in Q1 2026, an estimated $42.3K.
Boston Scientific made up 0.01% of HBK Sorce Advisory's portfolio in Q1 2026, its #396 holding.
HBK Sorce Advisory first reported a position in Boston Scientific in Q4 2018 and has held it in 15 quarters since.
HBK Sorce Advisory's Boston Scientific position peaked at $914K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on HBK Sorce Advisory's 13F filing for Q1 2026, filed 11 May 2026.